48 related articles for article (PubMed ID: 6230536)
1. Omeprazole suppresses endothelial calcium response and eNOS Ser1177 phosphorylation in porcine aortic endothelial cells.
Kamiya C; Odagiri K; Hakamata A; Sakurada R; Inui N; Watanabe H
Mol Biol Rep; 2021 Jul; 48(7):5503-5511. PubMed ID: 34291395
[TBL] [Abstract][Full Text] [Related]
2.
Zhang M; Yu W; Zhou S; Zhang B; Lo ECM; Xu X; Zhang D
Front Microbiol; 2021; 12():647611. PubMed ID: 33717046
[TBL] [Abstract][Full Text] [Related]
3. Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele MR; Vigneri S; Celle G
Dig Dis Sci; 1994 Jan; 39(1):161-8. PubMed ID: 8281852
[TBL] [Abstract][Full Text] [Related]
4. The pathophysiology of peptic ulcer disease.
Brooks FP
Dig Dis Sci; 1985 Nov; 30(11 Suppl):15S-29S. PubMed ID: 4053922
[TBL] [Abstract][Full Text] [Related]
5. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
6. Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.
Lauritsen K; Rune SJ; Wulff HR; Olsen JH; Laursen LS; Havelund T; Astrup L; Bendtsen F; Linde J; Bytzer P
Gut; 1988 Feb; 29(2):249-53. PubMed ID: 3278955
[TBL] [Abstract][Full Text] [Related]
7. U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group.
Valenzuela JE; Berlin RG; Snape WJ; Johnson TL; Hirschowitz BI; Colon-Pagan J; Morse RS; Petrozza J; Van Deventer GM; Cagliola A
Dig Dis Sci; 1991 Jun; 36(6):761-8. PubMed ID: 2032518
[TBL] [Abstract][Full Text] [Related]
8. Pump blockers and ulcer disease.
Sachs G
N Engl J Med; 1984 Mar; 310(12):785-6. PubMed ID: 6230536
[No Abstract] [Full Text] [Related]
9. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
McArthur KE; Jensen RT; Gardner JD
Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
[TBL] [Abstract][Full Text] [Related]
10. [Omeprazole--a drug-blocking proton pump of the parietal cells of the stomach].
Sosnowski M
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1469-72. PubMed ID: 3008128
[No Abstract] [Full Text] [Related]
11. Pharmacologic control of gastric acid secretion in peptic ulcer.
Konturek SJ
Mt Sinai J Med; 1983; 50(6):457-67. PubMed ID: 6141524
[No Abstract] [Full Text] [Related]
12. Treatment of ulcer disease.
Spenney JG
Ala J Med Sci; 1985 Jan; 22(1):49-53. PubMed ID: 3883827
[No Abstract] [Full Text] [Related]
13. [Antisecretory effect of losec and pariet in peptic ulcer therapy].
Nemytin IuV; Makarov IuS; Pavlov AI; Kashchenko OI; Lezhenina NP; Golochalova TV
Voen Med Zh; 2002 Oct; 323(10):44-6. PubMed ID: 12479006
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
